An adverse reaction to angiotensin-converting enzyme inhibitors in a patient with neglected C1 esterase inhibitor deficiency.
Ebo
D G
DG
Department of Immunology, Allergology and Rheumatology, University of Antwerpen, Belgium.
Stevens
W J
WJ
Bosmans
J L
JL
D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced* / Q000175:diagnosis*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency*; D003327:Coronary Disease / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy*; D008213:Lymphocyte Activation; D008297:Male; D012882:Skin Tests
D000806:Angiotensin-Converting Enzyme Inhibitors; D003174:Complement C1 Inactivator Proteins